Our Clinical Safety Officer, Haniyah Khanum, took the lead on this element of the project, working with the team to ensure DCB0129 compliance, the key requirement of the Clinical Safety section of DTAC.
Haniyah began by comprehensively assessing Smart Respiratory’s current practices and understanding of DCB0129 requirements. Recognising the need for a strong foundation, she organised a series of tailored training sessions and interactive hazard workshops. These sessions served a dual purpose; of educating the Smart Respiratory team on the intricacies of DCB0129 and facilitating a collaborative environment to identify potential risks associated with their products.
The hazard workshops proved particularly valuable, as they allowed the team to engage in critical thinking about their technology’s impact on patient safety alongside their medical device registration. Through this exercise, Smart Respiratory cross-functionally gained a deeper appreciation for the importance of risk mitigation in healthcare technology and saw the real value of a Clinical Safety Officer as part of their overall risk management process.
Recognising that DCB0129 compliance is an ongoing process, Haniyah focused on empowering Smart Respiratory’s team to maintain and update their compliance status independently, using internal resources to act as the Clinical Safety Officer. As a result, Haniyah supported the regulatory and clinical team members to ensure there was a smooth handover ensuring that Smart Respiratory could adapt their compliance framework as their products evolved, maintaining the highest standards of clinical safety.